CAM
VNDA icon

Costello Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Costello Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.3K Hold
2,500
– – ﹤0.01% 440
2026
Q1 		$17.3K Hold
2,500
– – 0.01% 412
2025
Q4 		$22.1K Buy
+2,500
New +$13.8K 0.01% 362

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Costello Asset Management's VNDA Position: Q2 2026 in Review

Costello Asset Management held its Vanda Pharmaceuticals (VNDA) position steady in Q2 2026 at 2,500 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #440.

Costello Asset Management first reported a position in VNDA in Q4 2025 and has held it in 3 quarters since. The position peaked at $22.1K in Q4 2025. 173 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Costello Asset Management held 2,500 shares of Vanda Pharmaceuticals worth $15.3K as of Q2 2026.
  • Costello Asset Management left its Vanda Pharmaceuticals share count unchanged in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Costello Asset Management's portfolio in Q2 2026, its #440 holding.
  • Costello Asset Management first reported a position in Vanda Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Costello Asset Management's Vanda Pharmaceuticals position peaked at $22.1K in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Costello Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.